Epidemiology and clinical biostatistics
2024 Activity indicators
- 1 competitive European grant led: JRC Tender
- 2 national public competitive projects led: ISCIII
- 3 private projects led
- 2 competitive HR contracts
- 52 publications
- IF: 280.90
- Q1 publications: 36 (69%)
- D1 publications: 16 (31%)
- 1 thesis
- Evaluators in different national institutions: 3 researchers
- 1 European patent application for an EIT Health project (EP21383224.9) with PCT PCT/EP2022/087806 "Chronic pain: Electrical Quantitative Sensory Assessment System for Failed Back Surgery Syndrome"
- 2 books with registered ISBNs (978-84-09-04309 and 978-84-09-04308) on MAPAC algorithms
- 2 intellectual property registrations: Metadisc 2.0 (application no.: 2110269633104) and APP MAPAC-DX (application no.: 2211082593771)
- Celebration of the 30th anniversary of the creation of the Biostatistics Unit at IRYCIS and its Ramón University Hospital
Milestones
- The Cochrane Centre of the Community of Madrid is part of the Ibero-American Cochrane Consortium, which has been selected as one of the 5 Evidence Synthesis Units recognized by Cochrane worldwide to apply for competitive funding for Evidence Synthesis for international organizations (WHO, PAHO, NICE, Welcome Trust).
- Award of an AES2024 coordinated project: "Development and external validation of a comprehensive model for predicting small newborn vulnerability. Convergent methods of primary research and synthesis. PREVENEP study" (PI24/01406).
- Award of an AES 2024 Río Hortega contract (CM24/00152).
- European funding by the Joint Research Centre (JRC) for updating recommendations for colorectal, breast, and cervical cancer screening and prevention in European clinical practice guidelines. (943473-IPR-2022).
- Publication of two Cochrane systematic reviews on diagnostic tests, in an international collaboration with the University of Birmingham (PMID: 39400904 and PMID: 39679851).
Bibliometrics
Articles | Accum. FI | Mean | Articles Q1 or Q2 | % in Q1 or Q2 | Articles D1 | % in D1 | |
---|---|---|---|---|---|---|---|
2020 | 58 | 279.19 | 4.81 | 38 | 66 | 20 | 34 |
2021 | 64 | 394.78 | 6.17 | 47 | 73 | 17 | 27 |
2022 | 51 | 629.49 | 14.31 | 40 | 78 | 20 | 39 |
2023 | 49 | 360.71 | 9.02 | 33 | 67 | 9 | 18 |
2024 | 52 | 280.90 | 6.25 | 45 | 87 | 16 | 31 |
274 | 1945.07 | 8.58 | 203 | 74 | 82 | 30 |
*Only original articles, editorials, guidelines and reviews.